Literature DB >> 3275932

Renal calcification incidence in very low birth weight infants.

J S Jacinto1, H D Modanlou, M Crade, A A Strauss, S K Bosu.   

Abstract

Serial ultrasound examinations were performed on 31 neonates with birth weights of less than 1,500 g for the detection of renal calcifications. Renal calcifications occurred in 20 (64%) of the infants at a mean age of 39.3 +/- 26.7 days of life. Infants with renal calcifications had shorter gestations (28.2 +/- 1.8 v 31 +/- 1.4 weeks, P less than .004) and lighter birth weights (924 +/- 195 v 1,338 +/- 100 g, P less than .004) than those infants without renal calcifications (n = 11). Furosemide administration was more common in the infants with renal calcifications (65% v 9.1%, P less than .001). The mean total dose of furosemide administered before renal calcifications were noted was 9.59 +/- 7.25 mg/kg. The 20 neonates with renal calcifications had a mean urine calcium level of 12.0 +/- 6.8 mg/kg/24 hours, mean urine calcium to creatinine ratio of 1.32 +/- 1.03 (range 0.3 to 4.45), and a mean alkaline phosphatase concentration of 961 +/- 327 IU. Initial parathyroid hormone levels were not different between the two groups, and subsequent determinations in infants with renal calcifications did not differ significantly from initial values. Renal calcifications are fairly common among very low birth weight infants, particularly in those receiving supplemental calcium and furosemide therapy. Although long-term implications of such findings are not known, close monitoring of renal function by serial determinations of urine calcium and urine calcium to creatinine ratios may identify those infants at risk for renal calcifications.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3275932

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  26 in total

1.  Nephrocalcinosis in preterm babies.

Authors:  A Narendra; M P White; H A Rolton; Z I Alloub; G Wilkinson; J H McColl; J Beattie
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-11       Impact factor: 5.747

Review 2.  Intestinal absorption and renal reabsorption of calcium throughout postnatal development.

Authors:  Megan R Beggs; R Todd Alexander
Journal:  Exp Biol Med (Maywood)       Date:  2017-04

3.  Renal calcification in preterm infants: follow up at 4-5 years.

Authors:  C A Jones; S King; N J Shaw; B A Judd
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-05       Impact factor: 5.747

4.  Intermittent administration of furosemide or continuous infusion in critically ill infants and children: does it make a difference?

Authors:  J Klinge
Journal:  Intensive Care Med       Date:  2001-04       Impact factor: 17.440

5.  Does citrate prevent nephrocalcinosis in preterm neonates?

Authors:  Eveline A Schell-Feith; Aukje Moerdijk; Paul H T van Zwieten; Harmine M Zonderland; Herma C Holscher; Joana Kist-van Holthe; Bert J van der Heijden
Journal:  Pediatr Nephrol       Date:  2006-10-13       Impact factor: 3.714

6.  Urinary saturation and nephrocalcinosis in preterm infants: effect of parenteral nutrition.

Authors:  B Hoppe; A Hesse; T Neuhaus; S Fanconi; I Forster; N Blau; E Leumann
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

7.  Development of nephrocalcinosis in very low birth weight infants.

Authors:  Guido Hein; Detlef Richter; Friedrich Manz; Dieter Weitzel; Hermann Kalhoff
Journal:  Pediatr Nephrol       Date:  2004-03-31       Impact factor: 3.714

8.  Renal stone formation following medical treatment of renal candidiasis.

Authors:  B C Cramer; R Ozere; W Andrews
Journal:  Pediatr Radiol       Date:  1990

9.  Urinary excretion of calcium and phosphate in preterm infants.

Authors:  Narendra Aladangady; Pietro G Coen; Madeleine P White; Margaret D Rae; T James Beattie
Journal:  Pediatr Nephrol       Date:  2004-11       Impact factor: 3.714

10.  Urinary lithogenic and inhibitory factors in preterm neonates receiving either total parenteral nutrition or milk formula.

Authors:  Vasilios I Giapros; Athanasios L Papaloukas; Anna S Challa; Panagiotis D Nikolopoulos; Constantine G Tsampoulas; Styliani K Andronikou
Journal:  Eur J Pediatr       Date:  2003-05-16       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.